title: [Efficiency of a pharmaceutical care program for long-acting parenteral antipsychotics in the health area of Santiago de Compostela].
abstract: In the healthcare area of Santiago de Compostela (Spain), the therapeutic subgroup "other antipsychotics" represented the fifth largest outpatient expenditure in 2013. More than half of this expenditure corresponded to long-acting parenteral forms of paliperidone and risperidone. Over a 12-month period, the implementation of a pharmaceutical care program based on process management and coordination of actions between health professionals in both levels of care represented savings of € 636,391.01 for the organization and a direct saving of € 16,767.36 and 9,008 trips to the pharmacy for patients. This study shows the efficiency of the program, which was facilitated by its situation in an area of integrated management and the use the unified medical records and electronic prescription, elements that will enable the future implementation of similar programmes. The new registries and healthcare interventions will allow reliable evaluation of their effectiveness in terms of treatment adherence, relapses and hospitalisations.
authors.affiliation: Gerencia de Gestión Integrada, Servizo Galego de Saúde, Xunta de Galicia, Santiago de Compostela (A Coruña), España. Electronic address: raquel.vazquez.mourelle@sergas.es.
authors.forename: Raquel
authors.initials: R
authors.lastname: Vázquez-Mourelle
authors.affiliation: Gerencia de Gestión Integrada, Servizo Galego de Saúde, Xunta de Galicia, Lugo, España.
authors.forename: Carmen Durán
authors.initials: CD
authors.lastname: Parrondo
authors.affiliation: Gerencia de Gestión Integrada, Servizo Galego de Saúde, Xunta de Galicia, Santiago de Compostela (A Coruña), España.
authors.forename: Estrella
authors.initials: E
authors.lastname: López-Pardo Pardo
authors.affiliation: Gerencia de Gestión Integrada, Servizo Galego de Saúde, Xunta de Galicia, Santiago de Compostela (A Coruña), España.
authors.forename: Eduardo
authors.initials: E
authors.lastname: Carracedo-Martínez
mesh_terms: D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000191:economics / Q000493:pharmacokinetics / Q000627:therapeutic use*; D002391:Catchment Area, Health; D017046:Cost Savings; D003362:Cost-Benefit Analysis; D003692:Delayed-Action Preparations; D019033:Delivery of Health Care, Integrated / Q000458:organization & administration*; D017598:Efficiency, Organizational; D055695:Electronic Prescribing; D006801:Humans; D007267:Injections; D000068882:Paliperidone Palmitate / Q000008:administration & dosage / Q000191:economics / Q000493:pharmacokinetics / Q000627:therapeutic use; D010593:Pharmaceutical Services / Q000458:organization & administration*; D010818:Practice Patterns, Physicians'; D011306:Prescription Fees; D018967:Risperidone / Q000008:administration & dosage / Q000191:economics / Q000493:pharmacokinetics / Q000627:therapeutic use; D013030:Spain
chemical_list: D014150:Antipsychotic Agents; D003692:Delayed-Action Preparations; D018967:Risperidone; D000068882:Paliperidone Palmitate
keywords: Agentes Antipsicóticos; Antipsychotic Agents; Health Care Delivery, Integrated; Palmitato de Paliperidona [concepto adicional]; Programas Sanitarios Regionales; Provisión Sanitaria Integrada; Regional Medical Programmes; Risperidona; Risperidone; paliperidone palmitate [Supplementary Concept]